Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Vera Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Pharmaceutical Preparations
No intraday reading yet this session.
222 institutional managers report a position in Vera Therapeutics, Inc. worth $3.4B between them, filed on form 13F for the quarter ending 2026-06-30. 28 of them hold 80% of it, the largest being BlackRock, Inc. at 7.34%.
197 more managers in the register
28 managers hold 80% of the $3.4B institutional base. The other 194 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
VERA (Vera Therapeutics, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: NVS +0.24%, in industrials & materials.
via Kynam Capital Management, LP, Deep Track Capital, LP, Logos Global Management LP +11 more · 3.69% of VERA, 6.21% of CLDX
via venBio Select Advisor LLC, Deep Track Capital, LP, Deerfield Management Co +5 more · 7.31% of VERA, 9.62% of GPCR
via Deep Track Capital, LP, Deerfield Management Co, Sofinnova Investments, Inc. +2 more · 5.11% of VERA, 8.09% of GMAB
via venBio Select Advisor LLC, Deep Track Capital, LP, Logos Global Management LP +3 more · 7.31% of VERA, 5.98% of OCUL
via venBio Select Advisor LLC, Deep Track Capital, LP, Bellevue Group AG +5 more · 7.31% of VERA, 5.32% of COAG
via Kynam Capital Management, LP, Deep Track Capital, LP, Bellevue Group AG +7 more · 3.69% of VERA, 4.72% of VRDN
Managers holding a meaningful stake in VERA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.